about
Recent developments in receptor tyrosine kinases targeted anticancer therapyClass III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisCellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressorTyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatmentIntertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase induced by polyethylene glycol bindingRole of protein tyrosine phosphatases in cancerFabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapyDysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesEvolution of a strategy for preparing bioactive small molecules by sequential multicomponent assembly processes, cyclizations, and diversificationKinase pathway dependence in primary human leukemias determined by rapid inhibitor screening.Cytostatic and cytotoxic effects of tyrphostin AG1296 on RMS cellsCell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent.Structure-based design, synthesis, molecular docking, and biological activities of 2-(3-benzoylphenyl) propanoic acid derivatives as dual mechanism drugs.An LC-MS/MS method for rapid and sensitive high-throughput simultaneous determination of various protein kinase inhibitors in human plasma.Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell linesTargeting kinases with anilinopyrimidines: discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily.Targeting the protein kinases for anti-cancer therapy.Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.Bioassay-Guided Isolation of Sesquiterpene Coumarins from Ferula narthex Bioss: A New Anticancer Agent.High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.The potential role of Aurora kinase inhibitors in haematological malignancies.Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics.Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women: A case-control study.Measuring and interpreting the selectivity of protein kinase inhibitorsQuinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluationPractical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.New Diethyl Ammonium Salt of Thiobarbituric Acid Derivative: Synthesis, Molecular Structure Investigations and Docking Studies.Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.Profiling the effects of short time-course cold ischemia on tumor protein phosphorylation using a Bayesian approach.AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.Dual role of GRK5 in cancer development and progression.Genomics of Esophageal Cancer and Biomarkers for Early Detection.Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors.
P2860
Q26751331-2A3A93C4-8186-493C-B88B-FB01F3988A0CQ26797245-94886B52-CA8B-4FA5-8CB2-15914175547BQ26863333-F156E0A3-30C1-4AC9-8514-E8518E5771A5Q26998914-6D70F83B-B329-4652-8DAA-E17DC1F91E85Q27653621-BE5685CE-D1B7-4DC4-BA70-272705C8D80AQ28741003-DEF573C1-575E-4C17-A5CE-19B3114A2869Q33684453-929CCBE6-42BE-4F40-9335-B269D5965E0AQ33828409-D90373CD-8EA7-427D-9F13-70A615A603C2Q34139691-3E53B7E1-B9F1-4C21-B146-9E82A19EF619Q34207033-7BFE3059-FC48-4F20-8798-A9C3C9314D3BQ34307423-FC1445BD-B3BC-4844-9079-4619CDE68D7FQ34780162-F15C9486-7372-43DC-9007-5BE1B4F21932Q35603983-95DF3210-EA47-4228-A024-8C10DCAA602CQ35769437-AA41B991-C74B-4A10-A7E6-9F9C0FC695C8Q35770449-8B14D952-C673-44DF-9E99-EB04768743FBQ36083906-C0DF3B16-45C7-4DF8-B5AE-D8588D5D26BCQ36226540-0DC3EEB6-4560-4C7A-B84B-DF8A30D8C2ADQ36280842-93F6A006-0055-4D4F-8577-2717E5EA0E34Q36297631-77FBC679-0317-4C64-8758-F8B73B2D7DBEQ36353657-382063DA-DE72-4931-B885-DA8B027C9B58Q36582512-21B09A07-323F-40D3-993A-D0176B170D1AQ36591388-A4A2238C-83BF-42AA-8E60-B5E1809560E4Q36911647-9A02989F-112E-437F-994A-EE78EF7E07B2Q36996552-02F86A35-69E6-46BC-9987-96747590E2A4Q37167047-E8CFFC76-417D-4DAB-91D1-779F59F174F5Q37203741-D23BD9AF-190E-4165-BECC-87E1A792EB8EQ37432991-2041BD9A-684D-4654-956F-3B75B259C048Q37537075-70688F88-0913-4B68-882C-559F80CCF4ACQ37992086-98D186E5-8E50-4126-ABC2-58771F8530C9Q38066199-CF8BA72E-A1FA-4883-B064-695F77733AB3Q38190857-D5C9958F-63D2-4BA4-8982-7D4FDA54A90AQ38402026-9CBAFB0A-7D19-4003-8281-9A0742DC07D5Q38546808-C357C3F0-D102-4F8A-A645-955367AECEC3Q38647605-9D314EA4-2F48-4A08-AE73-D10676F074AEQ38662464-E00AFA8B-4FDD-44AD-823C-A6A6B208CA59Q38727237-723C4A2A-7EA5-484D-9F65-7DACBB48EE72Q38834995-6C8A33C4-F41C-4904-BE6A-9BA615D2A1C7Q38871791-28F8D722-7F2C-43C1-8224-BBF55849AC40Q38940530-CB81F114-BA92-4EEF-941E-4C6763F11BC1Q38951816-0E079BF8-CC22-4FB4-8C80-3287699A6E68
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tyrosine kinase - Role and significance in Cancer
@nl
Tyrosine kinase - Role and significance in Cancer.
@ast
Tyrosine kinase - Role and significance in Cancer.
@en
type
label
Tyrosine kinase - Role and significance in Cancer
@nl
Tyrosine kinase - Role and significance in Cancer.
@ast
Tyrosine kinase - Role and significance in Cancer.
@en
altLabel
Tyrosine kinase – Role and significance in Cancer
@en
prefLabel
Tyrosine kinase - Role and significance in Cancer
@nl
Tyrosine kinase - Role and significance in Cancer.
@ast
Tyrosine kinase - Role and significance in Cancer.
@en
P2860
P3181
P356
P1476
Tyrosine kinase - Role and significance in Cancer
@en
P2093
Anup K Mukhopadhyay
P2860
P304
P3181
P356
10.7150/IJMS.1.101
P407
P50
P577
2004-06-01T00:00:00Z